An Aeromonas variant that produces aerolysin promotes susceptibility to ulcerative colitis
Science · 2025
DOI: 10.1126/science.adz4712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, 2025. Verfasst von Zhihui Jiang und 33 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology, National Resource Center for Mutant Mice, Department of Gastroenterology of Nanjing Drum Tower …. Hauptthemen laut MEDLINE: Aeromonas, Bacterial Toxins, Colitis, Ulcerative, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 70 Literaturangaben.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a severe inflammatory bowel disease affecting millions of people worldwide, but the factors driving the condition are poorly understood. In tissue samples from individuals with UC, we found that macrophages were depleted from areas of the colon that did not yet exhibit overt epithelial inflammation. We hypothesized that toxins produced by bacteria could impair macrophages and that this could promote wider inflammation. We isolated a variant of Aeromonas genus from stool samples from UC patients, which we termed macrophage-toxic bacteria (MTB), because aerolysin secreted by MTB caused macrophage death. MTB colonized mice under pathogenic conditions and triggered colitis. Antibodies against aerolysin alleviated colitis induced by Aeromonas in mice. In a cohort, UC patients more frequently tested positive for Aeromonas than healthy controls did.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Pharmaceutical Biotechnology, National Resource Center for Mutant Mice, Department of Gastroenterology of Nanjing Drum Tower Hospital, and Suqian Scientific Research Institute, Medical School of…
- Department of Gastroenterology and Department of General Surgery, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- Department of Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China.
- State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
- Department of Non-Communicable Disease Prevention, Nanjing Municipal Center for Disease Control and Prevention, Nanjing, China.
- Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China.
ORCID-Profile: Zhihui Jiang, Ye Wang, Jianfeng Gong, Xin Chen, Dong Hang, Caiping Chen, Yang Liao, Pengpeng Li, Zhuoxin Yang, Yuwei Zhou, Hairong Zhou, Feng Su, Weiqi He, Lei Fang, Zhenji Gan, Xia Gao, Huaqun Chen, Fangyu Wang, Xuena Zhang, Minsheng Zhu
Zitieren
APA
Jiang, Z., Wang, Y., Gong, J., Chen, X., Hang, D., Chen, C., Hong, X., Zhang, J., Qiu, K., Liao, Y., Li, P., Wang, H., Yang, Z., Qiu, T., Zhou, Y., Chen, Z., Zhou, H., Shan, X., Zhou, N., …, & Zhu, M. (2025). An Aeromonas variant that produces aerolysin promotes susceptibility to ulcerative colitis. Science. https://doi.org/10.1126/science.adz4712
Vancouver
Jiang Z, Wang Y, Gong J, Chen X, Hang D, Chen C, et al. An Aeromonas variant that produces aerolysin promotes susceptibility to ulcerative colitis. Science. 2025. doi:10.1126/science.adz4712
BibTeX
@article{Jiang2025,
author = {Jiang, Zhihui and Wang, Ye and Gong, Jianfeng and Chen, Xin and Hang, Dong and Chen, Caiping and Hong, Xin and Zhang, Junhao and Qiu, Kehui and Liao, Yang and Li, Pengpeng and Wang, Han and Yang, Zhuoxin and Qiu, Tiantian and Zhou, Yuwei and Chen, Zexu and Zhou, Hairong and Shan, Xinqi and Zhou, Na and Liu, Lutao and Feng, Fan and Su, Feng and Ma, Hongfeng and Liu, Zhifeng and He, Weiqi and Fang, Lei and Xuan, Ji and Gan, Zhenji and Gao, Xia and Zhang, Jian and Chen, Huaqun and Wang, Fangyu and Zhang, Xuena and Zhu, Minsheng},
title = {An Aeromonas variant that produces aerolysin promotes susceptibility to ulcerative colitis},
journal = {Science},
year = {2025},
doi = {10.1126/science.adz4712}
}
EUVIMED